Joel Haynes - Search Results

Year	Number of Results
1986	1
2002	4
2004	1
2005	2
2006	3
2008	1
2009	2
2011	1
2012	2
2019	1
2024	0

1

Haynes JR. Haynes JR. Expert Rev Vaccines. 2009 Apr;8(4):435-45. doi: 10.1586/erv.09.8. Expert Rev Vaccines. 2009. PMID: 19348559 Review.

2

Needle-free epidermal powder immunization.

Chen D, Maa YF, Haynes JR. Chen D, et al. Among authors: haynes jr. Expert Rev Vaccines. 2002 Oct;1(3):265-76. doi: 10.1586/14760584.1.3.265. Expert Rev Vaccines. 2002. PMID: 12901567 Review.

3

The role of particle-mediated DNA vaccines in biodefense preparedness.

Dean HJ, Haynes J, Schmaljohn C. Dean HJ, et al. Among authors: haynes j. Adv Drug Deliv Rev. 2005 Jun 17;57(9):1315-42. doi: 10.1016/j.addr.2005.01.012. Epub 2005 Apr 12. Adv Drug Deliv Rev. 2005. PMID: 15935876 Review.

4

Particle-mediated DNA vaccine delivery to the skin.

Haynes JR. Haynes JR. Expert Opin Biol Ther. 2004 Jun;4(6):889-900. doi: 10.1517/14712598.4.6.889. Expert Opin Biol Ther. 2004. PMID: 15174971 Review.

5

In Depth Breadth Analyses of Human Blockade Responses to Norovirus and Response to Vaccination.

Haynes J, Perry V, Benson E, Meeks A, Watts G, Watkins H, Braun R. Haynes J, et al. Viruses. 2019 Apr 26;11(5):392. doi: 10.3390/v11050392. Viruses. 2019. PMID: 31035476 Free PMC article.

6

H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizers.

Kissmann J, Joshi SB, Haynes JR, Dokken L, Richardson C, Middaugh CR. Kissmann J, et al. Among authors: haynes jr. J Pharm Sci. 2011 Feb;100(2):634-45. doi: 10.1002/jps.22304. J Pharm Sci. 2011. PMID: 20669328

7

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.

Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C. Haynes JR, et al. Vaccine. 2009 Jan 22;27(4):530-41. doi: 10.1016/j.vaccine.2008.11.011. Epub 2008 Nov 19. Vaccine. 2009. PMID: 19026705

8

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.

Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, Richardson C, Green KY. Parra GI, et al. Among authors: haynes jr. Vaccine. 2012 May 21;30(24):3580-6. doi: 10.1016/j.vaccine.2012.03.050. Epub 2012 Mar 31. Vaccine. 2012. PMID: 22469864 Free PMC article.

9

Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma.

Payne LG, Fuller DH, Haynes JR. Payne LG, et al. Among authors: haynes jr. Curr Opin Mol Ther. 2002 Oct;4(5):459-66. Curr Opin Mol Ther. 2002. PMID: 12435047 Review.

10

Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.

Haynes JR, Cunningham J, von Seefried A, Lennick M, Garvin RT, Shen SH. Haynes JR, et al. Biotechnology (N Y). 1986;4(7):637-641. doi: 10.1038/nbt0786-637. Biotechnology (N Y). 1986. PMID: 32226216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year